Waldron, N., Dunbar, P. R., Deva, S., Yoon, O. K., Ling, J., Lin, K., . . . Ang, E. Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWaldron, Nicholas, et al. Oral PD-L1 Inhibitor GS-4224 Selectively Engages PD-L1 High Cells and Elicits Pharmacodynamic Responses in Patients with Advanced Solid Tumors. BMJ Publishing Group.
MLA (9th ed.) CitationWaldron, Nicholas, et al. Oral PD-L1 Inhibitor GS-4224 Selectively Engages PD-L1 High Cells and Elicits Pharmacodynamic Responses in Patients with Advanced Solid Tumors. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.